January 28, 2019
January 2, 2019
A new Opioid Agonist Treatment Compliance and Management Program (OAT-CAMPP) for community pharmacy has been developed aimed at reducing stigma and expanding pharmacists’ knowledge about methadone, buprenorphine/naloxone and slow-release oral morphine.